Fidelis Capital Partners, LLC Quest Diagnostics Inc Transaction History
Fidelis Capital Partners, LLC
- $654 Billion
- Q1 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 379 shares of DGX stock, worth $51,957. This represents 0.11% of its overall portfolio holdings.
Number of Shares
379Holding current value
$51,957% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding DGX
# of Institutions
876Shares Held
96.2MCall Options Held
983KPut Options Held
436K-
Vanguard Group Inc Valley Forge, PA13.9MShares$1.91 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$1.47 Billion0.03% of portfolio
-
State Street Corp Boston, MA5.2MShares$713 Million0.03% of portfolio
-
Victory Capital Management Inc3.92MShares$538 Million0.53% of portfolio
-
American Century Companies Inc Kansas City, MO3.87MShares$531 Million0.33% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...